Views
2 years ago

Supplement

2016AbstractSupplement

Supplement to: VOL. 106 NO. 3S SEPTEMBER 2016 WWW.FERTSTERT.ORG ASRM 2016 Scientific Congress Supplement Scientific Congress Supplement: Oral and Poster Session Abstracts

  • Page 2 and 3: - - - - - - - - - - - - - - - - - -
  • Page 4 and 5: ‘‘RAD’’) or INK128 (mTORC1/
  • Page 6 and 7: needed to achieve pregnancy. ASRM h
  • Page 8 and 9: CONTRACEPTION AND FAMILY PLANNING O
  • Page 10 and 11: MALE REPRODUCTION AND UROLOGY: TRAV
  • Page 12 and 13: REPRODUCTIVE ENDOCRINOLOGY: RESEARC
  • Page 14 and 15: O-30 Monday, October 17, 2016 12:30
  • Page 16 and 17: trained minimally invasive gynecolo
  • Page 18 and 19: patients with a normal SIS compared
  • Page 20 and 21: TABLE 1. Egg Donor 42 Normal 62% 51
  • Page 22 and 23: chi square where applicable. Multiv
  • Page 24 and 25: RESULTS: In total, over 19,000 chro
  • Page 26 and 27: RESULTS: Main baseline characterist
  • Page 28 and 29: ENVIRONMENT AND REPRODUCTION O-67 M
  • Page 30 and 31: spermatozoa (p¼0.030 for soy milk)
  • Page 32 and 33: Probability of LB when undergoing H
  • Page 34 and 35: 2009 to 2015 were reviewed and thos
  • Page 36 and 37: Number of Oocytes Retrieved Outcome
  • Page 38 and 39: effect on ovarian as well as adrena
  • Page 40 and 41: Supported by: Funding for this stud
  • Page 42 and 43: is prohibited from covering in vitr
  • Page 44 and 45: objectives of this study are to des
  • Page 46 and 47: O-111 Tuesday, October 18, 2016 11:
  • Page 48 and 49: CONCLUSIONS: pET is associated with
  • Page 50 and 51: RESULTS: As expected, FSH deprivati
  • Page 52 and 53:

    co-transfection of LHR, AKAP13, and

  • Page 54 and 55:

    Pregnancy Outcomes & Multiple Pregn

  • Page 56 and 57:

    Endocrinology and Infertility, Depa

  • Page 58 and 59:

    References: 1. Hanna CB, Yao S, Ram

  • Page 60 and 61:

    Technologies TM ). A total of 179 p

  • Page 62 and 63:

    Live Birth Rate and Cost Effectiven

  • Page 64 and 65:

    MATERIALS AND METHODS: A survey reg

  • Page 66 and 67:

    O-161 Tuesday, October 18, 2016 12:

  • Page 68 and 69:

    RESULTS: A total of 38 PMCs were id

  • Page 70 and 71:

    O-172 Tuesday, October 18, 2016 12:

  • Page 72 and 73:

    O-177 Tuesday, October 18, 2016 11:

  • Page 74 and 75:

    Social Media Topics Ranked in Order

  • Page 76 and 77:

    Table 1: Live Birth Rate, Mean Cost

  • Page 78 and 79:

    in function. The AURKB variant enco

  • Page 80 and 81:

    17.9% (28 - 35 maternal age), howev

  • Page 82 and 83:

    Statistical Analysis of Hormone-SNP

  • Page 84 and 85:

    4 days and E2 on the last day (PE g

  • Page 86 and 87:

    DESIGN: Basic Science Cell Study MA

  • Page 88 and 89:

    O-216 Wednesday, October 19, 2016 1

  • Page 90 and 91:

    Comparison between the two studied

  • Page 92 and 93:

    conventional incubator with the Eev

  • Page 94 and 95:

    ENDOMETRIOSIS O-229 Wednesday, Octo

  • Page 96 and 97:

    Study 1 Endometrial Biopsy Results

  • Page 98 and 99:

    O-238 Wednesday, October 19, 2016 1

  • Page 100 and 101:

    Table 1. Group Characteristics (N¼

  • Page 102 and 103:

    OBESITY AND METABOLISM O-247 Wednes

  • Page 104 and 105:

    metabolites derived from microbial

  • Page 106 and 107:

    O-257 Wednesday, October 19, 2016 1

  • Page 108 and 109:

    were completed using mouse cleavage

  • Page 110 and 111:

    Race/Ethnicity USA birth cohort All

  • Page 112 and 113:

    for each year to determine if infer

  • Page 114 and 115:

    RESULTS: Overall, 8.7% of all women

  • Page 116 and 117:

    RESULTS: About half the donors repo

  • Page 118 and 119:

    P. C. Serafini, e,f E. Motta, g,c T

  • Page 120 and 121:

    P-34 Tuesday, October 18, 2016 OVAR

  • Page 122 and 123:

    Telomeropathies, such as Dyskeratos

  • Page 124 and 125:

    P-44 Tuesday, October 18, 2016 IN W

  • Page 126 and 127:

    activation hormon; 200 ug/kg, 400 u

  • Page 128 and 129:

    Ovarian Reserve, Response and Ferti

  • Page 130 and 131:

    P-59 Tuesday, October 18, 2016 PERU

  • Page 132 and 133:

    P-65 Tuesday, October 18, 2016 HIGH

  • Page 134 and 135:

    on EST due to history of stroke and

  • Page 136 and 137:

    -The most effective route of admini

  • Page 138 and 139:

    P-81 Tuesday, October 18, 2016 GNRH

  • Page 140 and 141:

    donation to other couples was highe

  • Page 142 and 143:

    P-93 Tuesday, October 18, 2016 THE

  • Page 144 and 145:

    lastocyst 55% vs.. 48%) and decreas

  • Page 146 and 147:

    Mitochondrial Content (MC) Arrested

  • Page 148 and 149:

    STEET vs. FSET vs. ZSET by age. n

  • Page 150 and 151:

    of treatment, decreasing time to pr

  • Page 152 and 153:

    CONCLUSIONS: High rates of aneuploi

  • Page 154 and 155:

    OBJECTIVE: To study ongoing pregnan

  • Page 156 and 157:

    The data was then transferred to an

  • Page 158 and 159:

    NGS Results for Donor Cycles aged 1

  • Page 160 and 161:

    P-141 Tuesday, October 18, 2016 ABS

  • Page 162 and 163:

    were obtained from patients who cho

  • Page 164 and 165:

    RESULTS: Interpretable results were

  • Page 166 and 167:

    ART OUTCOME PREDICTORS - CLINICAL P

  • Page 168 and 169:

    10-15 mm (Odds ratio (OR) 1.15, 95%

  • Page 170 and 171:

    Risks of Adverse Outcomes Compared

  • Page 172 and 173:

    Table 1: The effect of P on live bi

  • Page 174 and 175:

    Comparison of characteristics, clin

  • Page 176 and 177:

    DESIGN: A retrospective cohort stud

  • Page 178 and 179:

    clinically comparable with no influ

  • Page 180 and 181:

    (138/404, 34%). Blastocyst transfer

  • Page 182 and 183:

    P-201 Tuesday, October 18, 2016 IS

  • Page 184 and 185:

    OBJECTIVE: To describe trends and i

  • Page 186 and 187:

    P-212 Tuesday, October 18, 2016 REV

  • Page 188 and 189:

    9. Mansour, R., Fahmy, I., Tawab, N

  • Page 190 and 191:

    (27.5% vs. 5.67%/6.54%) and live bi

  • Page 192 and 193:

    3. Park JY, Su YQ, Ariga M, Law E,

  • Page 194 and 195:

    outcomes in the GnRH-antagonist gro

  • Page 196 and 197:

    However, the endometrial thickness

  • Page 198 and 199:

    infertility cases were excluded. CO

  • Page 200 and 201:

    CONCLUSIONS: TU pretreatment may be

  • Page 202 and 203:

    Table1:Comparison of protocols base

  • Page 204 and 205:

    RESULTS: Demographic variables of p

  • Page 206 and 207:

    Embryo Retention and Clinical Outco

  • Page 208 and 209:

    P-267 Tuesday, October 18, 2016 PRE

  • Page 210 and 211:

    References: 1. Shengli Lin, Rong Li

  • Page 212 and 213:

    P-277 Tuesday, October 18, 2016 END

  • Page 214 and 215:

    CONCLUSIONS: Exogenous gonadotropin

  • Page 216 and 217:

    RESULTS: 392 FETs with an endometri

  • Page 218 and 219:

    OBJECTIVE: It is well established t

  • Page 220 and 221:

    concept regarding the mechanisms of

  • Page 222 and 223:

    P-305 Tuesday, October 18, 2016 PRE

  • Page 224 and 225:

    Statistical methods used for compar

  • Page 226 and 227:

    Cycle Outcome and Kinetic Data PESA

  • Page 228 and 229:

    with both euploid per biopsy rate a

  • Page 230 and 231:

    DESIGN: This retrospective cohort s

  • Page 232 and 233:

    Semen parameters for paternally vs.

  • Page 234 and 235:

    5. ShamsiMB, Kumar R, Dada R. Evalu

  • Page 236 and 237:

    New Genetic Point mutation in NOA p

  • Page 238 and 239:

    RESULTS: 37/41 AZS patients but onl

  • Page 240 and 241:

    significantly in the majority of me

  • Page 242 and 243:

    ovaries from a 60-day-old mouse. Co

  • Page 244 and 245:

    P-364 Wednesday, October 19, 2016 V

  • Page 246 and 247:

    Demographic characteristics and cli

  • Page 248 and 249:

    Supported by: NIH R25 HD075737 and

  • Page 250 and 251:

    Changes in mean sperm characteristi

  • Page 252 and 253:

    P-385 Wednesday, October 19, 2016 P

  • Page 254 and 255:

    WEIGHT, PCOSQ AND STRESS OUTCOMES W

  • Page 256 and 257:

    P-395 Wednesday, October 19, 2016 H

  • Page 258 and 259:

    Table 2: IVF Cycle Outcomes Referen

  • Page 260 and 261:

    RESULTS: Single embryo transfer was

  • Page 262 and 263:

    RESULTS: PCOS subjects were younger

  • Page 264 and 265:

    OBJECTIVE: One of the methods to re

  • Page 266 and 267:

    overweight (25-29.9 kg/m 2 ), obese

  • Page 268 and 269:

    ENDOMETRIOSIS P-430 Wednesday, Octo

  • Page 270 and 271:

    CONCLUSIONS: In women with endometr

  • Page 272 and 273:

    CONCLUSIONS: This is the first stud

  • Page 274 and 275:

    Additionally medical therapy decrea

  • Page 276 and 277:

    CONCLUSIONS: The control of complem

  • Page 278 and 279:

    Changes in Lumbar Spine Bone Minera

  • Page 280 and 281:

    Characteristics of 29 women who und

  • Page 282 and 283:

    P-467 Wednesday, October 19, 2016 C

  • Page 284 and 285:

    Awareness, concern, and avoidance o

  • Page 286 and 287:

    glucose levels [mean (95% CI) mg/dL

  • Page 288 and 289:

    CONCLUSIONS: Incubator chamber spac

  • Page 290 and 291:

    MATERIALS AND METHODS: Both laborat

  • Page 292 and 293:

    similar to DGC-MACS. Sperm concentr

  • Page 294 and 295:

    fragment in the promoter region (-4

  • Page 296 and 297:

    Table1: Comparison of semen analysi

  • Page 298 and 299:

    used to compare groups. Significant

  • Page 300 and 301:

    of therapy and also underlines the

  • Page 302 and 303:

    The intra- and inter-observer relia

  • Page 304 and 305:

    in H 2 (H 2 +A) (n¼42); with roten

  • Page 306 and 307:

    Distribution of sperm head sizes an

  • Page 308 and 309:

    RESULTS: Mean (SD) male age was 377

  • Page 310 and 311:

    statistical significance of aneuplo

  • Page 312 and 313:

    CONCLUSIONS: Peak stimulation serum

  • Page 314 and 315:

    into two groups: (i) pregnant patie

  • Page 316 and 317:

    References: 1. Gardner, D.K., et al

  • Page 318 and 319:

    Implantation Success Rates by G-CSF

  • Page 320 and 321:

    disease risk visibility. For exampl

  • Page 322 and 323:

    P-568 Wednesday, October 19, 2016 C

  • Page 324 and 325:

    Donor egg (25) 35 years old. Cycles

  • Page 326 and 327:

    MATERIALS AND METHODS: All fresh an

  • Page 328 and 329:

    standardization and suggest the nee

  • Page 330 and 331:

    References: 1. Kerstin Bjuresten,Br

  • Page 332 and 333:

    References: 1. Burks H, Paulson R.

  • Page 334 and 335:

    to patients with both BMI > 25 (ove

  • Page 336 and 337:

    Table 1. Comparison of endometrial

  • Page 338 and 339:

    IMPLANTATION P-611 Wednesday, Octob

  • Page 340 and 341:

    RESULTS: Clustering analysis of 20

  • Page 342 and 343:

    EARLY PREGNANCY P-621 Wednesday, Oc

  • Page 344 and 345:

    E. S. Ginsburg, a P. Brady. a a Dep

  • Page 346 and 347:

    P-631 Wednesday, October 19, 2016 S

  • Page 348 and 349:

    SYCP3. All slides were mounted in V

  • Page 350 and 351:

    possibly improve blastocyst cell tr

  • Page 352 and 353:

    age-associated increases in chromos

  • Page 354 and 355:

    and vitrification. An internal stan

  • Page 356 and 357:

    MATERIALS AND METHODS: We performed

  • Page 358 and 359:

    P-664 Wednesday, October 19, 2016 I

  • Page 360 and 361:

    mean age of patients is 34.8 + 3.7

  • Page 362 and 363:

    Table 1. Single medium versus seque

  • Page 364 and 365:

    RESULTS: Embryos with implantation

  • Page 366 and 367:

    Prevalence of MetSyn and its compon

  • Page 368 and 369:

    Table 1. Group Characteristics (N¼

  • Page 370 and 371:

    significant difference in AMH, AFC

  • Page 372 and 373:

    etrieved and per 2-pronuclear (2-PN

  • Page 374 and 375:

    P-708 Wednesday, October 19, 2016 C

  • Page 376 and 377:

    LATE-BREAKING ABSTRACTS O-265 Wedne

  • Page 378 and 379:

    O-270 Wednesday, October 19, 2016 1

  • Page 380 and 381:

    Balmir, F., P-219 Balthazar, U., P-

  • Page 382 and 383:

    Csokmay, J., O-90 Cuellar, R., O-13

  • Page 384 and 385:

    Gumer, A., P-684 Gun-Eryilmaz, O.,

  • Page 386 and 387:

    Kohn, T. P., O-226 Kokeguchi, S., O

  • Page 388 and 389:

    Moley, K., O-247, P-281, P-284, P-4

  • Page 390 and 391:

    Roeca, C. M., O-184 Rogel, R., O-19

  • Page 392 and 393:

    Tan, T., P-145 Tanaka, A., O-159, O

  • Page 394 and 395:

    TOPIC INDEX ART- In Vitro Fertiliza

  • Page 396 and 397:

    AUTHOR AND SPOUSE/PARTNER DISCLOSUR

  • Page 398 and 399:

    Clementi, C. Coddington, C. Cohen,

  • Page 400 and 401:

    Hill, G. United Healthcare Women’

  • Page 402 and 403:

    Parfitt, D.-E. Parry, J. P. Parsons

  • Page 404 and 405:

    Simpson, A. Slayden, O. D. Snabes,

Fertility Road Magazine 46 - September/October 2018
ruoounu. nnSlunCIS&UINI-rOSIlnS - the Society for Reproductive ...
Caring for gametes - eshre
IVF/ET counseling session - Department of O&G, HKU - The ...
ASRM Annual Meeting 2013 - Accepted Authors - American Society ...
Patient Finance Information - Midland Fertility Services
Title : The art of making babies - IRCC
Patients Finance Information - Midland Fertility Services
ERL Research Report 2010, Vol. I - College of Veterinary Medicine ...
Reproduction, Fertility and Development - the Society for ...
The Reproductive System - Science with Mr. Enns
Fertility Preservation: An Update - Department of Medicine